Transferability of Real World Evidence to Support HTA Recommendations in Lower Income European Countries. [PDF]
Kaló Z +25 more
europepmc +1 more source
Key Stakeholders' Knowledge, Opinions, and Interests on Real-World Evidence in the Regulatory Process-Results of an EU-Wide Survey. [PDF]
Depner FL +11 more
europepmc +1 more source
Avelumab real-world use in advanced Merkel cell carcinoma: a systematic review and non-comparative meta-analysis. [PDF]
Freitag A +5 more
europepmc +1 more source
Value of Clinical Evidence and Health Economics and Outcomes Research (HEOR) Studies. [PDF]
Abrahao A, Ciepielewska M, Zinman L.
europepmc +1 more source
Real-World Evidence and Multidrug Resistant Infections: How Can We Leverage RWE to Improve Patient Outcome with the Novel Beta-Lactam and Beta-Lactam/Beta-Lactamase Inhibitor Combinations. [PDF]
Gatti M, Pea F.
europepmc +1 more source
Development of the Philippine guidance document for the use of real-world evidence for clinical assessment of health technologies. [PDF]
Tan-Lim CSC +10 more
europepmc +1 more source
Reply: Exploring a More Accessible and Affordable Live Attenuated Herpes Zoster Vaccine (SKYZoster®) in the Philippines. [PDF]
Baik SH, Kim HY.
europepmc +1 more source
Accelerating novel therapies for sickle cell disease with RWE: ASH RC Data Hub as a strategically coordinated registry network. [PDF]
Wood WA +10 more
europepmc +1 more source
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 21. [PDF]
Arora P, Ramagopalan SV.
europepmc +1 more source
Utilisation and real-world effectiveness of advanced therapies for inflammatory bowel disease in Middle Eastern populations: a systematic review. [PDF]
Quraishi MN +5 more
europepmc +1 more source

